The EPO’s recent workshop brought together experts to discuss academic patenting trends and commercialisation in Europe, highlighting the increasingly proactive role of universities in managing intellectual property (IP). Over the past two decades, European universities have doubled their patent applications, now contributing over 10% of all EPO patents. Despite Europe’s strong academic base, commercialisation remains challenging due to regulatory fragmentation and limited cross-border knowledge transfer within the EU.

Key Insights and Trends:

  1. Unified Patent Court (UPC) and Reduced Barriers: The newly established Unified Patent Court (UPC), with 18 participating EU member states, aims to reduce patenting costs and streamline the process across Europe. By creating a more accessible EU patent market, the UPC is expected to facilitate the entry of academic innovations into the wider market, reducing the regulatory and financial hurdles that universities face.
  2. Direct University Control Over IP: European universities are increasingly taking direct control of IP management, following the U.S. Bayh-Dole Act model, which has given American universities over 20 years of experience in commercialising academic research. However, universities require comprehensive IP, business development, and legal expertise to fully exploit this approach. Sweden remains an outlier, where “professor’s privilege” means patents are often filed indirectly, maintaining traditional academic autonomy.
  3. Fragmentation and Market Challenges: One panellist highlighted that Europe’s lack of a unified regulatory market and limited skilled mobility remain critical barriers to effective commercialisation. Unlike in regions like Silicon Valley where industry co-locates with universities, Europe’s fragmented regulatory landscape makes it difficult for spinouts to scale without relocating. They also argued for stronger co-location of industry and academia within Europe, emphasising the need for cohesive EU-wide support for commercialising academic IP.
  4. Impact of University Equity Policies: Universities vary significantly in their approach to retaining equity in spinouts. While some major EU universities typically take a 1-2% stake, some UK institutions take as much as 20-25%, which can discourage investment by diluting founder ownership too early. One panellist advised that universities should target equity stakes between 2-7% for most spinouts, especially in sectors like healthcare and pharma, where IP holds substantial commercial potential. Universities that lack commercialisation expertise are encouraged to partner with external agencies to manage IP and bring inventions to market, emulating venture-studio-type models.
  5. Deep Tech and Startups: The EPO’s “Deep Tech Finder” platform aims to connect academic research with the start-up ecosystem to bridge the gap between research and market application. Currently covering academic institutions, the platform will expand to research centres next year, promoting greater engagement between universities and industry partners.

Panel Discussions and Success Stories: Case studies from universities like TU Wien and Universitat Politecnica de Valencia showcased the importance of embedding entrepreneurial expertise within research teams. These universities’ success in commercialising innovations was largely due to targeted licensing strategies and collaborations with experienced entrepreneurs, which helped bridge the gap between lab research and viable products without needing relocation outside Europe. Successful spinouts often involved pairing researchers with seasoned business mentors to guide long-term commercialisation.

Key Takeaways:

  • IP and Commercialisation Capacity: Universities, especially in fields like healthcare and pharma, should adopt tailored IP strategies to maximise the commercial potential of academic innovations.
  • Unified Market Approach: The UPC is a promising development for streamlining IP processes in Europe, though additional support is needed to overcome regulatory and mobility barriers.
  • Entrepreneurial Support and Partnership Models: Effective commercialisation demands collaboration, with accelerators, mentorship, and partnerships critical for supporting researchers. Embedding entrepreneurs directly in research teams or through part-time entrepreneur-in-residence roles has proven effective for bridging the gap between invention and marketable products.

Overall, the workshop underscored the potential of IP-driven innovation within European universities, while highlighting the need for a cohesive EU framework to fully support academic commercialisation.

Links: